• Revision 12 - minor - created about 1 month ago by Henry Knipe ◉ - view changeset
  Date: 2025-02-20 01:11:48 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Micro-X Ltd, Shareholder (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Rohit Sharma
• Revision 11 - major - created 6 months ago by Henry Knipe ◉ - view changeset
  Date: 2024-09-25 22:57:53 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Micro-X Ltd, Shareholder (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Joachim Feger
• Revision 10 - major - created 6 months ago by Joachim Feger ◉ - view changeset
  Date: 2024-09-25 06:31:03 UTC Disclosures:

  At the time the revision was created Joachim Feger had no financial relationships to ineligible companies to disclose.

  View Joachim Feger's current disclosures Reviewed by: Rohit Sharma
• Revision 9 - major - created 6 months ago by Arlene Campos ◉ - view changeset
  Date: 2024-09-25 04:51:06 UTC Disclosures:

  At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.

  View Arlene Campos's current disclosures Reviewed by: Joachim Feger
• Revision 8 - major - created over 1 year ago by Andrew Murphy ◉ - view changeset
  Date: 2023-11-09 18:40:35 UTC Disclosures:

  At the time the revision was created Andrew Murphy had no financial relationships to ineligible companies to disclose.

  View Andrew Murphy's current disclosures Reviewed by: Henry Knipe
• Revision 7 - major - created over 1 year ago by Frank Gaillard ◉ ◈ - view changeset
  Date: 2023-07-17 00:57:31 UTC Disclosures:

  At the time the revision was created Frank Gaillard had the following disclosures:

  • Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Frank Gaillard's current disclosures Reviewed by: Joachim Feger
• Revision 6 - major - created over 2 years ago by Daniel J Bell ◉ - view changeset
  Date: 2022-12-13 17:51:37 UTC Disclosures:

  At the time the revision was created Daniel J Bell had no financial relationships to ineligible companies to disclose.

  View Daniel J Bell's current disclosures Reviewed by: Rohit Sharma
• Revision 5 - major - created over 2 years ago by Frank Gaillard ◉ ◈ - view changeset
  Date: 2022-12-04 03:50:14 UTC Disclosures:

  At the time the revision was created Frank Gaillard had the following disclosures:

  • Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
  • Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Frank Gaillard's current disclosures Reviewed by: Rohit Sharma
• Revision 4 - major - created over 2 years ago by Amanda Er ◉ - view changeset
  Date: 2022-12-04 02:36:31 UTC Disclosures:

  At the time the revision was created Amanda Er had the following disclosures:

  • Radiopaedia Events Pty Ltd, Speaker fees (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Amanda Er's current disclosures Reviewed by: Frank Gaillard
• Revision 3 - major - created over 2 years ago by Andrew Murphy ◉ - view changeset
  Date: 2022-10-20 04:12:08 UTC Disclosures:

  At the time the revision was created Andrew Murphy had no financial relationships to ineligible companies to disclose.

  View Andrew Murphy's current disclosures Reviewed by: Mohammad Taghi Niknejad
• Revision 2 - major - created over 2 years ago by Frank Gaillard ◉ ◈ - view changeset
  Date: 2022-10-20 02:59:05 UTC Disclosures:

  At the time the revision was created Frank Gaillard had the following disclosures:

  • Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
  • Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Frank Gaillard's current disclosures Reviewed by: Mohammad Taghi Niknejad
• Revision 1 - major - created over 2 years ago by Frank Gaillard ◉ ◈ - view changeset
  Date: 2022-10-20 02:27:00 UTC Disclosures:

  At the time the revision was created Frank Gaillard had the following disclosures:

  • Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
  • Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Frank Gaillard's current disclosures Reviewed by: Mohammad Taghi Niknejad

Unfortunately some older revisions may not be able to be viewed or restored.